Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;40(3):141-146.
doi: 10.1016/j.bj.2017.04.002. Epub 2017 May 30.

Preventing coronary artery lesions in Kawasaki disease

Affiliations
Review

Preventing coronary artery lesions in Kawasaki disease

Ho-Chang Kuo. Biomed J. 2017 Jun.

Abstract

A form of systemic vasculitis that affects mostly small and medium-sized vessels, Kawasaki disease (KD) is most commonly found in children under the age of 5 years old. Though its etiology is unknown, KD has been the most frequent acquired heart disease in developing countries. Its incidence has increased over recent decades in many centuries, including Japan, Korea, and China. The most severe complications of KD are coronary artery lesions (CAL), including dilation, fistula, aneurysm, arterial remodeling, stenosis, and occlusion. Aneurysm formation has been observed in 20-25% of KD patients that do not receive intravenous immunoglobulin (IVIG) treatment, and in 3-5% that do receive it. Coronary artery dilation has been found in about 30% of KD patients in the acute stage, although mostly in the transient form. Diminishing the occurrence and regression of CAL is a vital part of treating KD. In this review article, I demonstrate the clinical method to prevent CAL formation used at the Kawasaki Disease Center in Taiwan.

Keywords: Coronary artery lesion; Kawasaki disease; Prevention.

PubMed Disclaimer

References

    1. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–276. - PubMed
    1. Liang C.D., Kuo H.C., Yang K.D., Wang C.L., Ko S.F. Coronary artery fistula associated with Kawasaki disease. Am Heart J. 2009;157:584–588. - PubMed
    1. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–2771. - PubMed
    1. Wang C.L., Wu Y.T., Liu C.A., Kuo H.C., Yang K.D. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J. 2005;24:998–1004. - PubMed
    1. Burns J.C., Glode M.P. Kawasaki syndrome. Lancet. 2004;364:533–544. - PubMed

MeSH terms

Substances